Mark S. Link
From the Department of Medicine, UTSouthwestern Medical Center, Dallas, TX (M.S.L.); TIMI Study Group, Brigham and Women’s Hospital, Boston, MA (R.P.G., C.T.R., B.M.S., A.E.C., S.A.M., E.M.A., E.B.); Department of Medicine, University of Oulu, Finland (H.H.); Oulu University Hospital, Finland (H.H.); Heart and Health Foundation of Turkey, Ankara (A.O.); Daiichi-Sankyo Pharma Development, Munich, Germany (H.L.); and Daiichi-Sankyo Pharma Development, Edison, NJ (M.F.M.).
If you are interested in creating or editing a profile page please contact our editorial office.